Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age

por Schwarz, Tino F., Galaj, Andrzej, Spaczynski, Marek, Wysocki, Jacek, Kaufmann, Andreas M., Poncelet, Sylviane, Suryakiran, Pemmaraju V., Folschweiller, Nicolas, Thomas, Florence, Lin, Lan, Struyf, Frank
Publicado 2017

A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years

por Schwarz, Tino F., Huang, Li-Min, Valencia, Alejandra, Panzer, Falko, Chiu, Cheng-Hsun, Decreux, Annabelle, Poncelet, Sylviane, Karkada, Naveen, Folschweiller, Nicolas, Lin, Lan, Dubin, Gary, Struyf, Frank
Publicado 2019

Long‐term persistence of immune response to the AS04‐adjuvanted HPV‐16/18 vaccine in Chinese girls aged 9‐17 years: Results from an 8‐9‐year follow‐up phase III open‐label study...

por Hu, Yuemei, Zhang, Xiang, He, Yilin, Ma, Zhilong, Xie, Yan, Lu, Xiangbin, Xu, Yabin, Zhang, Yanqiu, Jiang, Yunyu, Xiao, Hui, Struyf, Frank, Folschweiller, Nicolas, Jiang, Johny, Poncelet, Sylviane, Karkada, Naveen, Jastorff, Archana, Borys, Dorota
Publicado 2020

Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays

por Robbins, Hilary A., Kemp, Troy J., Porras, Carolina, Rodriguez, Ana Cecilia, Schiffman, Mark, Wacholder, Sholom, Gonzalez, Paula, Schiller, John, Lowy, Douglas, Poncelet, Sylviane, Esser, Mark, Matys, Katie, Hildesheim, Allan, Pinto, Ligia A., Herrero, Rolando, Safaeian, Mahboobeh
Publicado 2014

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine

por Folschweiller, Nicolas, Behre, Ulrich, Dionne, Marc, Durando, Paolo, Esposito, Susanna, Ferguson, Linda, Ferguson, Murdo, Hillemanns, Peter, McNeil, Shelly A, Peters, Klaus, Ramjattan, Brian, Schwarz, Tino F, Supparatpinyo, Khuanchai, Suryakirian, Pemmaraju V, Janssens, Michel, Moris, Philippe, Decreux, Annabelle, Poncelet, Sylviane, Struyf, Frank
Publicado 2019

Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years...

por Puthanakit, Thanyawee, Huang, Li-Min, Chiu, Cheng-Hsun, Tang, Ren-Bin, Schwarz, Tino F., Esposito, Susanna, Frenette, Louise, Giaquinto, Carlo, McNeil, Shelly, Rheault, Paul, Durando, Paolo, Horn, Michael, Klar, Maximilian, Poncelet, Sylviane, De Simoni, Stéphanie, Friel, Damien, De Muynck, Benoit, Suryakiran, Pemmaraju V., Hezareh, Marjan, Descamps, Dominique, Thomas, Florence, Struyf, Frank
Publicado 2016

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized...

por Folschweiller, Nicolas, Teixeira, Julio, Joshi, Smita, Goldani, Luciano Z, Supparatpinyo, Khuanchai, Basu, Partha, Chotpitayasunondh, Tawee, Chetchotisakd, Ploenchan, Ruxrungtham, Kiat, Roteli-Martins, Cecilia, Grinsztejn, Beatriz, Quintana, Silvana Maria, Kumarasamy, Nagalingeswaran, Poongulali, Selvamuthu, Kulkarni, Vinay, Lin, Lan, Datta, Sanjoy K, Descamps, Dominique, Dodet, Monique, Dubin, Gary, Friel, Damien, Hezareh, Marjan, Karkada, Naveen, Meric Camilleri, Dorothee, Poncelet, Sylviane, Salaun, Bruno, Tavares-da-Silva, Fernanda, Thomas-Jooris, Florence, Struyf, Frank
Publicado 2020